Cardinal Health EBITDA 2012-2026 | CAH
Cardinal Health annual and quarterly EBITDA history from 2012 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Cardinal Health EBITDA for the quarter ending June 30, 2026 was $970M, a 52.28% increase year-over-year.
- Cardinal Health EBITDA for the twelve months ending June 30, 2026 was $3.569B, a 16.44% increase year-over-year.
- Cardinal Health 2026 annual EBITDA was $3.569B, a 16.44% increase from 2025.
- Cardinal Health 2025 annual EBITDA was $3.065B, a 56.94% increase from 2024.
- Cardinal Health 2024 annual EBITDA was $1.953B, a 35.25% increase from 2023.
|
Cardinal Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2026 | $3,569 |
| 2025 | $3,065 |
| 2024 | $1,953 |
| 2023 | $1,444 |
| 2022 | $85 |
| 2021 | $1,255 |
| 2020 | $-3,185 |
| 2019 | $3,060 |
| 2018 | $1,158 |
| 2017 | $2,837 |
| 2016 | $3,100 |
| 2015 | $2,612 |
| 2014 | $2,344 |
| 2013 | $1,393 |
| 2012 | $2,117 |
|
Cardinal Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-06-30 | $970 |
| 2026-03-31 | $757 |
| 2025-12-31 | $941 |
| 2025-09-30 | $901 |
| 2025-06-30 | $637 |
| 2025-03-31 | $937 |
| 2024-12-31 | $741 |
| 2024-09-30 | $750 |
| 2024-06-30 | $587 |
| 2024-03-31 | $546 |
| 2023-12-31 | $680 |
| 2023-09-30 | $140 |
| 2023-06-30 | $338 |
| 2023-03-31 | $747 |
| 2022-12-31 | $51 |
| 2022-09-30 | $308 |
| 2022-06-30 | $204 |
| 2022-03-31 | $84 |
| 2021-12-31 | $-786 |
| 2021-09-30 | $583 |
| 2021-06-30 | $342 |
| 2021-03-31 | $672 |
| 2020-12-31 | $660 |
| 2020-09-30 | $-419 |
| 2020-06-30 | $495 |
| 2020-03-31 | $786 |
| 2019-12-31 | $564 |
| 2019-09-30 | $-5,030 |
| 2019-06-30 | $549 |
| 2019-03-31 | $693 |
| 2018-12-31 | $757 |
| 2018-09-30 | $1,061 |
| 2018-06-30 | $-828 |
| 2018-03-31 | $805 |
| 2017-12-31 | $690 |
| 2017-09-30 | $491 |
| 2017-06-30 | $630 |
| 2017-03-31 | $791 |
| 2016-12-31 | $708 |
| 2016-09-30 | $708 |
| 2016-06-30 | $796 |
| 2016-03-31 | $815 |
| 2015-12-31 | $732 |
| 2015-09-30 | $757 |
| 2015-06-30 | $673 |
| 2015-03-31 | $707 |
| 2014-12-31 | $658 |
| 2014-09-30 | $574 |
| 2014-06-30 | $502 |
| 2014-03-31 | $618 |
| 2013-12-31 | $636 |
| 2013-09-30 | $588 |
| 2013-06-30 | $-320 |
| 2013-03-31 | $574 |
| 2012-12-31 | $594 |
| 2012-09-30 | $545 |
| 2012-06-30 | $490 |
| 2012-03-31 | $610 |
| 2011-12-31 | $527 |
| 2011-09-30 | $490 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $54.109B | $254.248B |
| Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.? | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |